STAAR Surgical (NASDAQ: STAA)
STAAR Surgical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
STAAR Surgical Company Info
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
News & Analysis
Staar Surgical's Net Income Soars 108%
Staar Surgical's sales grew, but it delivered mixed signals on profitability.
Why STAAR Surgical Stock Dropped Today
The implantable lens specialist posted a mixed quarter and lowered its 2023 outlook.
Why Shares of STAAR Surgical Jumped 23.7% This Week
The new CEO made a major purchase of the company's stock on Monday.
2 Ravenously Growing Stocks to Buy and Hold No Matter What
Both companies are facing headwinds that will soon be a thing of the past.
Why STAAR Surgical Stock Is Triumphant Today
Its latest earnings update shows that its products are in hot demand worldwide.
Should You Buy Stocks When the Market Crashes?
If you can do it and still sleep at night, then yes.
After Falling More Than 56% in a Year, Is STAAR Surgical Doomed?
The stock price isn't tightly connected to its fundamentals.
Why STAAR Surgical Stock Dropped 12% This Week
Concerns about a potential drop in consumer spending may have hurt the stock.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.